Overview
Hyperparathyroidism-jaw tumor syndrome is a rare genetic disorder characterized by hyperparathyroidism, ossifying fibromatosis of the jaw, and an increased risk of renal tumors and nephroblastomatosis 2.Diagnosis
Presence of hyperparathyroidism with elevated calcium levels 2
Ossifying fibromatosis or fibrous lesions in the jaw 2
Renal hamartomas or nephroblastomatosis 2
Macrosomia and visceromegaly in affected individuals 2
Unusual facial features and potential early lethality 2
Consider differential diagnosis in cases of fetal ascites without hydrops 2Management
Treatment primarily focuses on managing hyperparathyroidism, often requiring parathyroidectomy 2
Surveillance for renal tumors and nephroblastomatosis with regular imaging studies 2
No specific drug treatments mentioned for the syndrome itself 12Special Populations
No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 2Key Recommendations
Perform regular monitoring for hypercalcemia and renal abnormalities in affected individuals (Evidence: Expert opinion) 2
Consider surgical intervention for severe hyperparathyroidism (Evidence: Expert opinion) 2
Early surveillance imaging for renal tumors and nephroblastomatosis is recommended (Evidence: Expert opinion) 2References
1 Cammalleri L, Malaguarnera M. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. International journal of medical sciences 2007. link
2 Greenberg F, Stein F, Gresik MV, Finegold MJ, Carpenter RJ, Riccardi VM et al.. The Perlman familial nephroblastomatosis syndrome. American journal of medical genetics 1986. link